Literature DB >> 17606558

A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality.

Laurie A Steiner1, Matthew J Bizzarro, Richard A Ehrenkranz, Patrick G Gallagher.   

Abstract

OBJECTIVE: Our goal was to identify trends in patient demographics and indications for and complications related to neonatal exchange transfusion over a 21-year period in a single institution using a uniform protocol for performing the procedure.
METHODS: A retrospective chart review of 107 patients who underwent 141 single- or double-volume exchange transfusions from 1986-2006 was performed. Patients were stratified into 2 groups, 1986-1995 and 1996-2006, on the basis of changes in clinical practice influenced by American Academy of Pediatrics management guidelines for hyperbilirubinemia.
RESULTS: There was a marked decline in the frequency of exchange transfusions per 1000 newborn special care unit admissions over the 21-year study period. Patient demographics and indications for exchange transfusion were similar between groups. A significantly higher proportion of patients in the second time period received intravenous immunoglobulin before exchange transfusion. There was a higher proportion of patients in the 1996-2006 group with a serious underlying condition at the time of exchange transfusion. During that same time period, a lower proportion of patients experienced an adverse event related to the exchange transfusion. Although a similar percentage of patients in both groups experienced hypocalcemia and thrombocytopenia after exchange transfusion, patients treated from 1996-2006 were significantly more likely to receive calcium replacement or platelet transfusion. No deaths were related to exchange transfusion in either time period.
CONCLUSIONS: Improvements in prenatal and postnatal care have led to a sharp decline in the number of exchange transfusions performed. This decline has not led to an increase in complications despite relative inexperience with the procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17606558     DOI: 10.1542/peds.2006-2910

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

1.  Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.

Authors:  Mohsen Saleh Elalfy; Nancy Samir Elbarbary; Heba Wegdan Abaza
Journal:  Eur J Pediatr       Date:  2010-10-06       Impact factor: 3.183

2.  Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria.

Authors:  Joshua Aderinsola Owa; Tinuade A Ogunlesi; Titus A Ogunlesi
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

3.  Irradiance readings of phototherapy equipment: Nigeria.

Authors:  Joshua Aderinsola Owa; Olusegun Joseph Adebami; Folorunso Francis Fadero; Tina Marye Slusher
Journal:  Indian J Pediatr       Date:  2011-02-22       Impact factor: 1.967

4.  Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?

Authors:  Susan E Wiedmeier; Timothy M Bahr; Robin K Ohls; Thomas R Christensen; Vickie L Baer; Sarah J Ilstrup; Kelly Cail; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521

5.  Irradiance levels of phototherapy devices: a national study in Dutch neonatal intensive care units.

Authors:  C V Hulzebos; S J Van't Klooster; K Lorenz; H J Vreman; P H Dijk
Journal:  J Perinatol       Date:  2017-03-02       Impact factor: 2.521

6.  Phototherapy for Neonatal Unconjugated Hyperbilirubinemia: Examining Outcomes by Level of Care.

Authors:  Eric Herschel Fein; Scott Friedlander; Yang Lu; Youngju Pak; Rie Sakai-Bizmark; Lynne M Smith; Caroline J Chantry; Paul J Chung
Journal:  Hosp Pediatr       Date:  2019-01-03

7.  A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion.

Authors:  Bolajoko O Olusanya; Folashade B Osibanjo; Adeniyi A Ajiboye; Oluwafemi E Ayodele; Adebanke A Odunsi; Serah M Olaifa; Abieyuwa A Emokpae
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-20

8.  Phototherapy and Risk of Type 1 Diabetes.

Authors:  Thomas B Newman; Andrea C Wickremasinghe; Eileen M Walsh; Barbara A Grimes; Charles E McCulloch; Michael W Kuzniewicz
Journal:  Pediatrics       Date:  2016-10-19       Impact factor: 7.124

9.  Exchange Transfusion for Severe Neonatal Hyperbilirubinemia: 17 Years' Experience from Vojvodina, Serbia.

Authors:  Nevenka Bujandric; Jasmina Grujic
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-02       Impact factor: 0.900

10.  Delayed cord clamping in red blood cell alloimmunization: safe, effective, and free?

Authors:  Ryan M McAdams
Journal:  Transl Pediatr       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.